Solas BioVentures Welcomes David Blackburn to Development Team
OCOTOBER 6, 2021
Chattanooga, TN - October 6, 2021 - Solas BioVentures is pleased to announce the addition of David Blackburn to the team. David is a graduate of the University of Tennessee at Knoxville and will become an integral part of the capital development team at Solas.
David brings a wealth of talent and experience from a 30-year career in leadership roles in higher education, including administrative and advisory positions at the University of Tennessee, UT-Chattanooga, and Middle Tennessee State University. During his time at these institutions, David has presided over tens of millions of dollars in annual budgets and capital campaigns.
“Having known and worked directly with David (“DB”) the past twenty years brings incredible comfort to the Solas management team and its investors. He has the highest integrity and always is there as a loyal friend and advisor to our limited partners.” said Dr. David Adair, Co-Founder and Managing Partner of Solas BioVentures.
“We’re very excited to have David join the Solas team. We know he’ll make a great addition, given his experience, personality, and professionalism,” added Mark Hackett, Co-Founder and General Partner.
ABOUT SOLAS BIOVENTURES:
Solas BioVentures invests exclusively in the Life Science industry, focusing primarily on early and development stage Biotech and Medtech companies. Solas is headquartered in Chattanooga, Tennessee, but our coverage is global. The Investment Team combines decades of medical, biotechnology, operational, managerial, legal, and financial experience. Solas maintains a founder- centric approach to foster breakthrough medicine and technology innovation.